Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
出版年份 2015 全文链接
标题
Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 11, Pages e0142035
出版商
Public Library of Science (PLoS)
发表日期
2015-11-17
DOI
10.1371/journal.pone.0142035
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Malaria eradication and elimination: views on how to translate a vision into reality
- (2015) Marcel Tanner et al. BMC Medicine
- P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections
- (2015) David C. Whitacre et al. PLoS One
- Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies
- (2014) F. Zabel et al. JOURNAL OF IMMUNOLOGY
- GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
- (2014) Christopher H. Clegg et al. PLoS One
- IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
- (2014) Robert Schwenk et al. PLoS One
- Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
- (2014) Petr O. Ilyinskii et al. VACCINE
- Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers
- (2014) Jenny G.H. Low et al. VACCINE
- Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint
- (2013) Michael D. Porter et al. Clinical and Vaccine Immunology
- The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection
- (2013) Michael T. White et al. PLoS One
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses
- (2013) Thomas J. Powell et al. VACCINE
- Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection
- (2012) Nicole Schmitz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro
- (2012) Tirth R. Ghimire et al. IMMUNOLOGY LETTERS
- Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity
- (2012) Cassandra Aldrich et al. PLoS One
- Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
- (2012) James J. Moon et al. PLoS One
- Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
- (2012) Stephen A. Kaba et al. PLoS One
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
- (2012) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus‑like particles as a vaccine delivery system: Myths and facts
- (2011) Polly Roy et al. Human vaccines & immunotherapeutics
- Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
- (2011) Steven E Kern et al. MALARIA JOURNAL
- Therapeutic vaccines for chronic diseases: successes and technical challenges
- (2011) M. F. Bachmann et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- (2011) Alexander D. Douglas et al. Nature Communications
- Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
- (2009) Nicole Schmitz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria
- (2009) S. A. Kaba et al. JOURNAL OF IMMUNOLOGY
- The development of the RTS,S malaria vaccine candidate: challenges and lessons
- (2009) W. R. BALLOU PARASITE IMMUNOLOGY
- High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
- (2009) Sheetij Dutta et al. PLoS One
- Development of the RTS,S/AS malaria candidate vaccine
- (2009) Johan Vekemans et al. VACCINE
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial
- (2008) Jacques Cornuz et al. PLoS One
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now